The TRICAPITAL-led round will fund team expansion and sector diversification for the Edinburgh fintech.
"In the new world, AI can be adopted throughout the customer journey, driving new insight, significant efficiency gains and better protecting the vulnerable. It’s a win-win situation. By using AI to help automate processes like quality assurance and risk monitoring, material cost reductions can be achieved. At the same time, companies gain targeted insights on customer experience and training opportunities for customer-facing staff."
The EdTech scale-up has raised £450k in a convertible loan note led by Scottish Enterprise to fund its entry into North American markets.
"I had to give presentations 2 or 3 times a week as part of my degree. I was getting so frustrated spending hours preparing every week only to forget key information during my presentation."
The funding round was backed by Skyscanner co-founder Gareth Williams alongside Scottish Enterprise and Equity Gap.
"This is hugely exciting news and is a change of trajectory from our original, more modest ambitions – we are now set on the path for Boundary to become a top-tier European home security business. To have someone with the calibre of Gareth giving our product his backing and mentorship is incredible; we have massive plans for the future."
The seed round was led by Equity Gap with backing from Scottish Enterprise to fund broader domestic and global expansion.
"We were painfully aware of how outdated methods and tools were no longer fit to deliver the rapid change needed for businesses to survive. We’re all being challenged to deliver more, and at a faster and faster rate, but we still face the stress and frustration of misalignment and surprises in projects."
The University of Edinburgh spin-out has secured backing to fund its first human trials.
"The BioCollector is a disruptive technology which will be transformational for liquid biopsy testing. We are confident that this platform technology can make a significant impact in this important area and, ultimately, enable cancers to be detected more quickly and accurately, enabling patients to receive precision cancer treatment as early as possible."
